Thrombolytic Therapy in Acute Ischemic Stroke

Werner Hacke, Gregory J. DelZoppo, Matthias Hirschberg (Herausgeber)

Buch | Softcover

XII, 271 Seiten

1991 | 1991
Springer Berlin (Verlag)
978-3-540-53680-2 (ISBN)

Artikel merken

During the last decade scientists in both basic and clinical research have renew ed their interest in the potential role of thrombolytic therapy in the treatment of acute ischemic stroke. The reevaluation of this approach was kindled by our growing knowledge of the pathogenesis of thrombotic and embolic stroke and by the development of new thrombolytic agents. With no proven therapy for acute ischemic stroke available, the potential value of early pharmacologic recanalization of occluded vessels in the management of acute stroke patients - an approach that has been supported by animal experiments and a limited number of uncontrolled clinical pilot studies - is again under scrutiny. A sym posium on "Thrombolysis in Acute Cerebral Ischemia" was held in Heidel berg, Germany, in May 1990 to summarize and discuss the pathophysiological background for thrombolysis in acute ischemic stroke and the recent ex perimental and clinical experience with the new generation of thrombolytic agents. The editors are fortunate to be able to include authoritative manuscripts from almost all the speakers at the symposium. These include reports of work by the most active investigators in this challenging field. The editors wish to express their gratitude to all the contributors for the additional work they have undertaken. Additionally, we would like to thank Springer-Verlag, Heidelberg, for its generous assistance in the preparation and rapid publication of this volume. Heidelberg, August 1990 WERNER HACKE GREGORY J. DEL ZopPO MATTHIAS HIRSCHBERG Contents I.

I. Acute Cerebral Ischemia and Thrombolysis.- Natural History of Atherothromboembolic Occlusion of Cerebral Arteries: Carotid Versus Vertebrobasilar Territories.- Fibrinolysis: Thrombolytic Agents, Mechanisms, and New Developments.- Fibrinolysis in Myocardial Infarction: Lessons for Cerebrovascular Disease.- Reperfusion of Ischemic Brain: Why and Why Not!.- Thrombolysis in Stroke: Timing of Recanalization and Its Clinical Consequences.- The Ischemic Penumbra: Fact or Fiction?.- Hemorrhagic Transformation in the Natural History of Acute Embolic Stroke.- Intracranial Hemorrhage After Coronary Thrombolysis with Tissue Plasminogen Activator.- Predictive Factors for the Effective Treatment of Acute Stroke with Intravenous Thrombolytic Agents.- Invasive Imaging Techniques in the Evaluation of Patient Selection and Cerebrovascular Recanalization.- The Role of Noninvasive Imaging Techniques in Cerebrovascular Recanalization.- II. Thrombolysis and Stroke Models.- Thrombolytic Therapy in Ischemic Stroke: Relevance and Limitations of Animal Models.- Update on Animal Model Experience with Recombinant Tissue Plasminogen Activator.- III. Clinical Trials.- Clinical Trials: Some General Considerations.- Intraarterial Urokinase Plasminogen Activator and Streptokinase in Carotid and Vertebrobasilar Territory Stroke: Clinical Outcome.- Fibrinolytic Recanalization Therapy in Acute Cerebrovascular Thromboembolism.- Intravenous Recombinant Tissue Plasminogen Activator in Acute Thrombotic Stroke: Study Design, Recanalization, and Clinical Outcome.- Evaluation of Tissue Plasminogen Activator Early in the Course of Acute Ischemic Stroke.- Intravenous Recombinant Tissue Plasminogen Activator in Acute Stroke.- Thrombolytic Therapy in Embolic and Thrombotic Cerebral Infarction: A Cooperative Study.- IV. Future Directions.- Problems in Formulating Therapeutic Trials.- Invasive and Noninvasive Vascular Imaging Techniques and Their Role in Clinical Stroke Trials.- Strategies for Early Treatment of Acute Cerebral Infarction.- V. Open Communications.- Topical Intraarterial Urokinase Infusion for Acute Stroke.- Local Thrombolytic Therapy in Acute Basilar Artery Occlusion: Experience with 18 Patients.- Vertebrobasilar Occlusion: Outcome With and Without Local Intraarterial Fibrinolysis.- Recanalization of Acute Middle Cerebral Artery Occlusion Monitored by Transcranial Doppler Sonography.- Neuropathological Findings After Thrombolytic Therapy in Acute Ischemic Stroke.- How Many Stroke Patients Are Candidates for Thrombolysis?.- Spontaneous Recanalization in Middle Cerebral Artery Occlusion.- In Vitro Thrombus Lysis by Urokinase in Preparation for Patient Studies.- Local Intraarterial Fibrinolysis in Acute Middle Cerebral Artery Occlusion.- Treatment of Acute Ischemic Stroke with Recombinant Tissue Plasminogen Activator: Evaluation with Regional Cerebral Blood Flow Single Photon Emission Computed Tomography.- Thrombolytic Therapy in Acute Ischemic Stroke: The Copenhagen Multicenter Study.- Thrombolytic Therapy in Cerebral Sinus Thrombosis: A Case Report.- Basilar Artery Occlusion Associated with Protein C Deficiency: Successful Treatment Using Recombinant Tissue Plasminogen Activator Infusion.- Intracerebral Hemorrhage and Infarction Volume Following Recombinant Tissue Plasminogen Activator in an Acute Stroke Model.- Prourokinase Therapy in Stroke.

Erscheint lt. Verlag	11.6.1991
Zusatzinfo	XII, 271 p. 26 illus.
Verlagsort	Berlin
Sprache	englisch
Maße	155 x 235 mm
Gewicht	450 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie
Themenwelt	Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren ► Radiologie
Schlagworte	Arteries • brain • Cerebral ischemia • Computed tomography (CT) • Imaging techniques • ischemic stroke • Schlaganfall • sonography • Thrombolyse • Tomography • zerebrale Ischämie • zerebravaskuläre Erkrankung
ISBN-10	3-540-53680-9 / 3540536809
ISBN-13	978-3-540-53680-2 / 9783540536802
Zustand	Neuware